NM
Navrattan Munjal
About Navrattan Munjal
Data last updated:
Navrattan Munjal is a Managing Director at Ind Swift Laboratories Limited (since 1995), Director at Nimbua Greenfield (Punjab) Association (since 2010) and Managing Director at Essix Biosciences Limited (since 1993), and holds 2 more current directorships. The companies operate in Pharma, Environment and Business Services. The 5 current companies with reported revenue have a combined latest revenue of ₹1,126 Cr; the largest is Ind Swift Laboratories Limited at ₹1,116 Cr (FY 2025). Earlier, Navrattan Munjal was a Director at Pharmaceuticals Export Promotion Council Of India (2007–2017) and Director at Saidpura Envirotech Private Limited (2014–2022) and 4 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 04 Jan 1995 | 1995 | ₹1,116 Cr (FY 2025) | Active | |
| Director | 26 Jun 2010 | 2004 | ₹5.90 Cr (FY 2025) | Active | |
| Managing Director | 24 Sep 1993 | 1993 | ₹3.45 Cr (FY 2025) | Active | |
| Director | 02 Jan 2023 | 2022 | ₹40.3 Lakh (FY 2025) | Active | |
| Director | 18 Sep 2012 | 2012 | ₹13.8 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 12 Nov 2007 | 2004 | ₹35.95 Cr (FY 2024) | Active | |
| Director | 24 Jan 2014 | 2014 | Active | ||
| Director | 17 Aug 2011 | 1983 | Active | ||
| Director | 11 Dec 2006 | 1986 | ₹560 Cr (FY 2024) | Amalgamated | |
| Director | 12 Jul 2005 | 2005 | ₹1.1 Lakh (FY 2017) | Amalgamated | |
| Director | 10 Mar 2010 | 2005 | ₹3,157 (FY 2017) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Navrattan Munjal
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Navrattan Munjal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Navrattan Munjal
Navrattan Munjal currently holds 5 directorships: Ind Swift Laboratories Limited (Managing Director, since 04 Jan 1995, revenue ₹1,116 Cr (FY 2025)); Nimbua Greenfield (Punjab) Association (Director, since 26 Jun 2010, revenue ₹5.90 Cr (FY 2025)); Essix Biosciences Limited (Managing Director, since 24 Sep 1993, revenue ₹3.45 Cr (FY 2025)); Mjm Remedies Private Limited (Director, since 02 Jan 2023, revenue ₹40.3 Lakh (FY 2025)); Mohali Green Environment Private Limited (Director, since 18 Sep 2012, revenue ₹13.8 Lakh (FY 2025)).
Navrattan Munjal was first appointed on 24 Sep 1993 as Managing Director at Essix Biosciences Limited. The most recent appointment on record is 02 Jan 2023 at Mjm Remedies Private Limited.
The 5 current companies of Navrattan Munjal that report revenue have a combined latest revenue of ₹1,126 Cr: Ind Swift Laboratories Limited ₹1,116 Cr (FY 2025); Nimbua Greenfield (Punjab) Association ₹5.90 Cr (FY 2025); Essix Biosciences Limited ₹3.45 Cr (FY 2025); Mjm Remedies Private Limited ₹40.3 Lakh (FY 2025); Mohali Green Environment Private Limited ₹13.8 Lakh (FY 2025).
Navrattan Munjal held 6 earlier board appointments: Pharmaceuticals Export Promotion Council Of India (Director, 12 Nov 2007 to 09 Jan 2017); Saidpura Envirotech Private Limited (Director, 24 Jan 2014 to 27 May 2022); Velox Shipping And Logistics Limited (Director, 17 Aug 2011 to 29 Sep 2012); Ind Swift Limited (Director, from 11 Dec 2006); N R M Portfolios Private Limited (Director, from 12 Jul 2005); and 1 more.
The current boards of Navrattan Munjal's companies include Gagan Aggarwal (Ind Swift Laboratories Limited), Himanshu Jain (Ind Swift Laboratories Limited), Neerja Chathley (Ind Swift Laboratories Limited), Pardeep Verma (Ind Swift Laboratories Limited), Prabhat Khurana (Ind Swift Laboratories Limited), Rajinder Kumar Gupta (Ind Swift Laboratories Limited), among others.